Onepot AI raises $13M to help make chemical drug creation easier

Onepot AI emerged from stealth with $13M in funding to accelerate small-molecule synthesis for drug discovery. The company built POT-1, an automated synthesis lab, and Phil, an AI chemist that learns from real-world experiments rather than literature data. Their platform allows biotech and pharma companies to order custom compounds that are synthesized and shipped within days instead of months, addressing a major bottleneck in drug development. The technology uses LLM agents trained on detailed experimental data to discover viable molecular combinations, aiming to make drug discovery twice as fast while expanding what's chemically possible.